Fig. 3.
Fig. 3. Development of human CD34+ cells in the hematopoietic tissues of NOD/SCID mice. (A) Typical profiles of human progenitor cell (CD34, CD33), myeloid cell (CD13, CD14), B-cell (CD19), and T-cell (CD2) surface markers on huCD45+ output cells from the BM, spleen, and PB of repopulated mice. Cells in the glycophorin A+ gate were 100% huCD71+ and 0% to 3% huCD45+. Quantification of the CD34+ population was done by using a four parameter gating method.31 (B) In the rare cases where huCD45+ cells populated the thymus (two mice), the vast majority (98%) were huCD2+ (upper histogram). When the thymic population was gated on huCD3+ cells (which comprised 72% of the total cells), 95% were hu CD4/CD8 double positive cells (lower histogram).

Development of human CD34+ cells in the hematopoietic tissues of NOD/SCID mice. (A) Typical profiles of human progenitor cell (CD34, CD33), myeloid cell (CD13, CD14), B-cell (CD19), and T-cell (CD2) surface markers on huCD45+ output cells from the BM, spleen, and PB of repopulated mice. Cells in the glycophorin A+ gate were 100% huCD71+ and 0% to 3% huCD45+. Quantification of the CD34+ population was done by using a four parameter gating method.31 (B) In the rare cases where huCD45+ cells populated the thymus (two mice), the vast majority (98%) were huCD2+ (upper histogram). When the thymic population was gated on huCD3+ cells (which comprised 72% of the total cells), 95% were hu CD4/CD8 double positive cells (lower histogram).

Close Modal

or Create an Account

Close Modal
Close Modal